Abstract
Characteristics and evolution of 38 patients with rheumatic diseases and COVID-19 under DMARD therapy
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have